TMO vs TVRD · P/E 24, rev $23.00B vs rev $2.6M
Thermo Fisher Scientific Inc (TMO) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. TVRD currently screens at market cap $0.
Not investment advice. Open the TMO and TVRD stock pages for the full models.
Not investment advice.